| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT05840835 | Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors | UNKNOWN | PHASE1, PHASE2 | 2023-02-03 | 2024-01-24 | 2024-01-24 |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | UNKNOWN | PHASE1, PHASE2 | 2018-02-15 | 2023-12-31 | 2023-10-31 |